Growing threat from counterfeit medicines - Bulletin of the World Health Organization, Apr 2010
Scratch & Win War Is Waged on Africa’s Fake Malaria Medicines
Counterfeit pills flood U.S.: How to spot fakes
U.S. agents search for dangerous foreign drugs in mail - Miami Herald
Cambodia takes action in fight against substandard and counterfeit medicines - press release from United States Pharmacopeial Convention.
European Parliament committee votes to regulate online pharmacies
Mobile startup takes on drug counterfeiters
Awash in Fake Drugs, Nigerians Fight Back
Fake medicines: Illegal, immoral and liable to increase drug resistance - Financial Times
More buy risky drugs on internet - New Zealand
The Dangers of Counterfeit Drugs (Voice of America)
Impact of poor-quality medicines in the ‘developing’ world
Spurious and counterfeit drugs: a growing industry in the developing world.
USAID Press Release - Growing Threat of Substandard and Counterfeit Medicines in Developing Countries Addressed by New USAID-USP Cooperative Agreement
EPHA Press Release - Position on Counterfeit Medicines
Kenya's Anti-Counterfeiting Act Challenged As Violating The Right To Health
Drugs still most knocked-off products says the Indonesian Anti-Counterfeiting Society
EU says fake medicines on the rise
Substandard medicines in resource-poor settings: a problem that can no longer be ignored.
Europe Awash in Counterfeit Drugs
The development process for pharmaceuticals (all types) as it has evolved over the past decades can be divided into four parts:
- Drug Discovery - Drug Discovery is the closest to pure science
- Animal Studies
- Clinical Trials in Humans
- Commercialization - packaging and manufacture
Commercialization is the marketing and distribution of the approved drug. Companies may participate in some or all of the phases. It is common for partnerships and licensing deals to happen. The nature and type of animal studies vary greatly, depending on the class of drug and any related products already approved by the FDA. The clinical trial process is well defined by FDA rules and regulations and by industry practice. It is composed of 3 (or 4) phases.